Trial · NCT01331837
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 18 of 18
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time to First Cardiovascular (CV) Events Adjudication Committee (EAC) (CV-EAC) Adjudicated Event | From baseline up to 4.9 years | Prospective comparison of time to first occurrence of any component of the composite of CV death (including events adjudicated as 'Undetermined Cause of Death'), non-fatal myocardial infarction, or non-fatal stroke. |
| Primary | Percentage of Patients Reporting a Cardiovascular (CV) Events Adjudication Committee (EAC) (CV-EAC) Adjudicated Event | From baseline up to 4.9 years | Percentage of patients reporting any component of the composite of CV death (including events adjudicated as 'Undetermined Cause of Death'), non-fatal myocardial infarction, or non-fatal stroke |
| Primary | Time to First CV-EAC Adjudicated Event - Sensitivity Analysis | From Baseline up to 4.9 years | Prospective comparison of time to first occurrence of any component of the composite of CV death (including events adjudicated as 'Undetermined Cause of Death'), non-fatal myocardial infarction, or non-fatal stroke - Sensitivity Analysis |
| Primary | Percentage of Patients With a CV-EAC Adjudicated Event - Sensitivity Analysis | From Baseline up to 4.9 years | Percentage of patients with any component of the composite of CV death (including events adjudicated as 'Undetermined Cause of Death'), non-fatal myocardial infarction, or non-fatal stroke - Sensitivity Analysis |
| Primary | Time to First CV-EAC Adjudicated Event Excluding Undetermined Cause of Death - Sensitivity Analysis | From baseline up to 4.9 years | Prospective comparison of time to first occurrence of any component of the composite of CV death (excluding events adjudicated as 'Undetermined Cause of Death'), non-fatal myocardial infarction, or non-fatal stroke - Sensitivity Analyses |
| Primary | Percentage of Patients With a CV-EAC Adjudicated Event Excluding Undetermined Cause of Death - Sensitivity Analysis | From baseline up to 4.9 years | Percentage of patients with any component of the composite of CV death (excluding events adjudicated as 'Undetermined Cause of Death'), non-fatal myocardial infarction, or non-fatal stroke - Sensitivity Analyses |
| Primary | Time to First CV-EAC Adjudicated Event Before Last Direct Contact Date | From Baseline up to 4.9 years | Prospective comparison of time to first occurrence of any component of the composite of CV death (including events adjudicated as 'Undetermined Cause of Death'), non-fatal myocardial infarction, or non-fatal stroke before last direct contact date (i.e., latest date of visit, IVRS call, or site call). |
| Primary | Percentage of Participants With a CV-EAC Adjudicated Event Before Last Direct Contact Date | From Baseline up to 4.9 years | Percentage of participants with any component of the composite of CV death (including events adjudicated as 'Undetermined Cause of Death'), non-fatal myocardial infarction, or non-fatal stroke before last direct contact date (i.e., latest date of visit, IVRS call, or site call). |
| Secondary | The Time to First Occurrence of an Expanded CV Composite Endpoint | From baseline up to 4.9 years | Prospective comparison of the time to first ccurrence of the expanded composite endpoint. The expanded composite endpoint is defined as the CV composite of the primary endpoint with the addition of non-elective coronary revascularization procedures and hospitalization for unstable angina. |
| Secondary | Percentages of Participants With an Expanded CV Composite Endpoint | From baseline up to 4.9 years | Percentages of participants with the expanded CV composite endpoint. The expanded composite endpoint is defined as the CV composite of the primary endpoint with the addition of non-elective coronary revascularization procedures and hospitalization for unstable angina. |
| Secondary | Time to First Occurrence of Individual Component of Primary Endpoint: Non-fatal Myocardial Infarction | From baseline up to 4.9 years | Prospective comparison of time to first occurrence of Individual component of primary endpoint: non-fatal Myocardial Infarction |
| Secondary | Percentage of Patients With Individual Component of Primary Endpoint: Non-fatal Myocardial Infarction | From baseline up to 4.9 years | Percentage of patients reporting Individual component of primary endpoint: non-fatal Myocardial Infarction |
| Secondary | Time to First Occurrence of Individual Component of Primary Endpoint: Cardiovascular Death | From baseline up to 4.9 years | Prospective comparison of time to first occurrence of Individual component of primary endpoint: cardiovascular death |
| Secondary | Percentage of Patients With Individual Component of Primary Endpoint: Cardiovascular Death | From baseline up to 4.9 years | Percentage of patients reporting Individual component of primary endpoint: cardiovascular death |
| Secondary | Time to First Occurrence of Individual Component of Primary Endpoint: Non-fatal Stroke | From baseline up to 4.9 years | Prospective comparison of time to first occurrence of Individual component of primary endpoint: non-fatal stroke |
| Secondary | Percentage of Patients With Individual Component of Primary Endpoint: Non-fatal Stroke | From baseline up to 4.9 years | |
| Secondary | Time to First Occurrence of Individual Component of Primary Endpoint: All-cause Mortality | From baseline up to 4.9 years | Prospective comparison of time to first occurrence of Individual component of primary endpoint: All-cause mortality |
| Secondary | Percentage of Patients With Individual Component of Primary Endpoint: All-cause Mortality | From baseline up to 4.9 years | Percentage of patients reporting Individual component of primary endpoint: All-cause mortality |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01331837/registered